Legal

  • £40m research hub reaches practical completion

    The £40m hub building that will house The Rosalind Franklin Institute on Oxford's Harwell Science and Innovation campus has reached practical completion. With the construction company handing legal ownership to UK Research and Innovation (UKRI), the Franklin will now commence specialist scientific fit-out. The Franklin, funded through UKRI’s Engineering and Physical Sciences Research Council (EPSRC), [...]

  • Senior appointment at Exscientia

    Clinical stage AI drug discovery company Exscientia has appointed a new executive vice president of strategic alliances. Dr Richard Law joins from Evotec where he was senior vice president of business development for more than seven years and previously head of computational chemistry. Prior to Evotec, Law was a senior computational chemistry researcher at the [...]

  • Life science professionals seek lasting post-COVID changes

    Almost three quarters of life sciences professionals believe COVID-19 will compromise their ability to conduct and analyse clinical trials in the next 12 month, data suggests. As a consequence of the coronavirus pandemic, 41% of global clinical trials in fields other than COVID-19 have been delayed or put on permanent hold. Looking ahead, 74% of life science [...]

  • Tech boss warns of track and trace flaw

    The CEO of a British tech company has warned the Government of potential serious flaws in the security of personal information and data used in the new contact tracing app technology announced by Matt Hancock. Manchester tech inventor and innovator Louis-James Davis stated that the use of QR code scanning technology - which underpins the Government contact tracing app [...]

  • Maintaining compliance in the search for breakthrough treatments

    Diana Jabbar-Lopez on rare diseases, patient data and how life science organisations can maintain compliance in the search for breakthrough treatments. There are thousands of rare diseases with often only a few hundred people worldwide diagnosed with a single condition. Finding enough patients who fit the right criteria for a rare disease clinical trial is [...]